Human Metalloenzymes Are Disproportionately Linked to Disease: The HEAM Structural Annotation Resource
- 1University of Kansas
Abstract
Catalytic metal-binding sites are established drug targets for many human diseases, yet systematic study of how metal function relates to disease is limited by the lack of a resource combining structural localization of human metal-binding sites with catalytic annotation at scale. We introduce HEAM (the Human Enzymatic Annotation of Metalloproteins), a structurally annotated dataset of 1,933 human metalloenzymes and 1,171 non-catalytic metalloproteins. HEAM incorporates annotated metals into protein structures at their corresponding binding sites and classifies each site as catalytic or non-catalytic using the machine learning classifier MAHOMES II. HEAM more than quadruples the human site-level coverage of the largest prior metalloenzyme database. Using HEAM, we show that human metalloproteins are significantly enriched in KEGG disease pathways relative to the human proteome, and that metalloenzymes specifically are significantly enriched in ClinVar pathogenic variants -- a distinction obscured in prior, catalytically unresolved metalloprotein datasets. These pathogenic variants are concentrated in metabolic disorders, indicating that metabolic dysfunction is a substantial contributor to metalloenzyme-linked disease. By pairing 3D structural annotation with catalytic classification, HEAM provides both a foundation for structure-guided drug design against metal-binding sites and a resource for determining how catalytic and non-catalytic metal function contribute to human disease.
Related
- Structural diversity of human urinary N-glycans revealed by reversed-phase LC/MS/MS toward a resource for biomarker discovery
- From Materials to Metalloenzymes: Superconducting Microresonators for Characterization of Thin Films
- MetabDB: an integrated resource for human metabolic measures, disease associations, and genetic evidence
- Mechanical regulation of LINC complex function: structural basis, physiological roles, and disease mechanisms in transnuclear mechanotransduction
- Structural features and disease-associated functions of ADGRV1: insights from signaling mechanisms.
BibTeX
@misc{miller2026human,
title = {{Human Metalloenzymes Are Disproportionately Linked to Disease: The HEAM Structural Annotation Resource}},
author = {E. Miller and S. Lim and M. M. Copeland and J. S. G. Slusky},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.09.758104},
url = {https://www.biorxiv.org/content/10.64898/2026.10.09.758104v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Human Metalloenzymes Are Disproportionately Linked to Disease: The HEAM Structural Annotation Resource
AU - E. Miller
AU - S. Lim
AU - M. M. Copeland
AU - J. S. G. Slusky
PY - 2026
DA - 2026/10/09
PB - bioRxiv
DO - 10.64898/2026.10.09.758104
UR - https://www.biorxiv.org/content/10.64898/2026.10.09.758104v1
AB - Catalytic metal-binding sites are established drug targets for many human diseases, yet systematic study of how metal function relates to disease is limited by the lack of a resource combining structural localization of human metal-binding sites with catalytic annotation at scale. We introduce HEAM (the Human Enzymatic Annotation of Metalloproteins), a structurally annotated dataset of 1,933 human metalloenzymes and 1,171 non-catalytic metalloproteins. HEAM incorporates annotated metals into protein structures at their corresponding binding sites and classifies each site as catalytic or non-catalytic using the machine learning classifier MAHOMES II. HEAM more than quadruples the human site-level coverage of the largest prior metalloenzyme database. Using HEAM, we show that human metalloproteins are significantly enriched in KEGG disease pathways relative to the human proteome, and that metalloenzymes specifically are significantly enriched in ClinVar pathogenic variants -- a distinction obscured in prior, catalytically unresolved metalloprotein datasets. These pathogenic variants are concentrated in metabolic disorders, indicating that metabolic dysfunction is a substantial contributor to metalloenzyme-linked disease. By pairing 3D structural annotation with catalytic classification, HEAM provides both a foundation for structure-guided drug design against metal-binding sites and a resource for determining how catalytic and non-catalytic metal function contribute to human disease.
ER -